The 8k refers to co-founders of IR-Med, Mr. Aharon
Post# of 87021
(Total Views: 417)
Posted On: 07/16/2024 12:06:19 PM
The 8k refers to co-founders of IR-Med, Mr. Aharon Kleinand and
Dr. Yaniv Cohen and their new amended consulting agreements between the company. https://www.otcmarkets.com/filing/html?id=176...ex10-1_htm
Aharon Klein , co-founded Ir. Med, Ltd in September 2013 and served as director since then and Chief Operating Officer from September 2013 until the date of the Acquisition. Upon the Acquisition, he was appointed Chief Technology Officer in. Mr. Klein is a medical device and biotech expert, with a strong clinical background. Prior to founding the Company, from 2004 to 200,7 Mr. Klein co-founded and served as CEO of Fertiligent, a start-up company focused on innovative fertility treatments, which was acquired by a United Kingdom based investment group in 2008. From 2008 to 2013, immediately prior to co-founding the Company, he founded a medical device company developing infrared based diagnostic tools for diagnosing colon cancer insito without the need for biopsies (optical biopsies). Mr. Klein graduated from the Faculty of Engineering in the Technion Israel Institute of Technology. Mr. Klein is experienced in initiating and running medical device start-up companies, including development running clinical trials and regulatory affairs.
Dr. Yaniv Cohen
Co founder & CSO, Director
Dr. Yaniv Cohen PhD MSc, co-founder of IR-Med, is a skilled scientist and entrepreneur, with years of experience leading R&D development for medical devices companies. His fields of expertise include electro-optics, infrared spectroscopy and medical devices using infrared light.
He has successfully led the development of medical devices from early concept to commercial product. His current research at Prof. Avigdor Scherz’s lab at the Weizmann Institute of Science is focused on the launch of Immune Photo Activated Cancer Therapy treatment for solid tumors.
Previous work experience includes Cisco and Tokyo Electron Israel. Dr. Cohen earned his Ph.D. from the world-renowned National Research
Executive Team
https://investors.ir-medical.com/company-info...utive-team
Dr. Yaniv Cohen and their new amended consulting agreements between the company. https://www.otcmarkets.com/filing/html?id=176...ex10-1_htm
Aharon Klein , co-founded Ir. Med, Ltd in September 2013 and served as director since then and Chief Operating Officer from September 2013 until the date of the Acquisition. Upon the Acquisition, he was appointed Chief Technology Officer in. Mr. Klein is a medical device and biotech expert, with a strong clinical background. Prior to founding the Company, from 2004 to 200,7 Mr. Klein co-founded and served as CEO of Fertiligent, a start-up company focused on innovative fertility treatments, which was acquired by a United Kingdom based investment group in 2008. From 2008 to 2013, immediately prior to co-founding the Company, he founded a medical device company developing infrared based diagnostic tools for diagnosing colon cancer insito without the need for biopsies (optical biopsies). Mr. Klein graduated from the Faculty of Engineering in the Technion Israel Institute of Technology. Mr. Klein is experienced in initiating and running medical device start-up companies, including development running clinical trials and regulatory affairs.
Dr. Yaniv Cohen
Co founder & CSO, Director
Dr. Yaniv Cohen PhD MSc, co-founder of IR-Med, is a skilled scientist and entrepreneur, with years of experience leading R&D development for medical devices companies. His fields of expertise include electro-optics, infrared spectroscopy and medical devices using infrared light.
He has successfully led the development of medical devices from early concept to commercial product. His current research at Prof. Avigdor Scherz’s lab at the Weizmann Institute of Science is focused on the launch of Immune Photo Activated Cancer Therapy treatment for solid tumors.
Previous work experience includes Cisco and Tokyo Electron Israel. Dr. Cohen earned his Ph.D. from the world-renowned National Research
Executive Team
https://investors.ir-medical.com/company-info...utive-team
(5)
(1)